Biomarkers in Alzheimer's disease: Evaluation of platelets, hemoglobin and vitamin B12
Santos, Gustavo Alves Andrade dos; Pardi, Paulo Celso.
Dement. neuropsychol
; 14(1): 35-40, Jan.-Mar. 2020. tab
Artigo Inglês | LILACS | ID: biblio-1089807
Documentos relacionados
Markers of Vitamin B12 Status in Relation to Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Cognitive Performance.
A Plasmonic Fluor-Lightened Microneedle Array Enables Ultrasensitive Multitarget Whole Blood Diagnosis of Anemia in A Paper Origami-Based Device.
Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease.
Association of Alzheimer's dementia with oral bacteria, vitamin B12, folate, homocysteine levels, and insulin resistance along with its pathophysiology, genetics, imaging, and biomarkers.
Do we treat dementia of the Alzheimer type or Alzheimer's disease? Anti-dementia drugs in the era of biomarkers
Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis.
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease.
Glucose-oxygen coupling can serve as a biomarker for neuroinflammation-related genetic variants.
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.